Market Cap
€737.3 Million
EUR as of July 1, 2024
US$791.9 Million
| Company | Market Cap (USD) |
|---|---|
Abbott
|
$216.15 B |
Boston Scientific Corporation
|
$140.40 B |
Stryker
|
$133.15 B |
Medtronic
|
$123.20 B |
Edwards Lifesciences Corporation
|
$50.10 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
Johnson & Johnson
|
$499.57 B |
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
UnitedHealth Group
|
$304.72 B |
Finland
languages
Healthcare
languages
Medical Devices
Finland Healthcare
Finland Medical Devices
Revenio Group Oyj has the following listings and related stock indices.
Stock: OMXH: REG1V
Stock: Munich: R0V
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.